Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
Cong-Qiu Chu
No abstract text is available yet for this article.
July 29, 2021: Rheumatology
#2
Viking Huss, Hannah Bower, Hjalmar Wadström, Thomas Frisell, Johan Askling
OBJECTIVE: To estimate the occurrence and relative risks of first ever incident non-cutaneous cancer overall and by 16 sites in patients with RA treated with biologic and targeted synthetic DMARDs (b/tsDMARDs), by time since treatment start, attained age, and time on active treatment. METHODS: Observational nationwide and population-based cohort study of patients with RA(n = 69 308), treated with TNF inhibitors (TNFi; adalimumab, certolizumab, etanercept, golimumab, infliximab) or other b/tsDMARDs (abatacept, rituximab, baricitinib, tofacitinib and tocilizumab) compared with RA patients not treated with b/tsDMARDs, and matched general population referents (n = 109 532), 2001-2018...
July 29, 2021: Rheumatology
#3
Kunal Chandwar, Prasanna Dogga, Juhi Dixit, Digvijay Ekbote, Kriti Kishor, Puneet Kumar
No abstract text is available yet for this article.
July 29, 2021: Rheumatology
#4
Martina Orlandi, Nicholas Landini, Gianluca Sambataro, Cosimo Nardi, Lorenzo Tofani, Cosimo Bruni, Silvia Bellando-Randone, Jelena Blagojevic, Daniela Melchiorre, Michael Hughes, Christopher P Denton, Fabrizio Luppi, Barbara Ruaro, Francesca Della Casa, Francesca W Rossi, Giacomo De Luca, Corrado Campochiaro, Michele Spinicci, Lorenzo Zammarchi, Sara Tomassetti, Antonella Caminati, Edoardo Cavigli, Marco Albanesi, Fabio Melchiorre, Stefano Palmucci, Virginia Vegni, Serena Guiducci, Alberto Moggi-Pignone, Yannick Allanore, Alessandro Bartoloni, Marco Confalonieri, Lorenzo Dagna, Francesco De Cobelli, Amato De Paulis, Sergio Harari, Dinesh Khanna, Masataka Kuwana, Gloria Taliani, Federico Lavorini, Vittorio Miele, Giovanni Morana, Alberto Pesci, Carlo Vancheri, Stefano Colagrande, Marco Matucci-Cerinic
OBJECTIVE: To identify the main computed tomography (CT) features that may help distinguishing a progression of interstitial lung disease (ILD) secondary to Systemic sclerosis (SSc) from COVID-19 pneumonia. METHODS: This multicentric study included 22 international readers divided in the radiologist group (RAD) and non-radiologist group (nRAD). A total of 99 patients, 52 with COVID-19 and 47 with SSc-ILD, were included in the study. RESULTS: Fibrosis inside focal ground glass opacities (GGO) in the upper lobes; fibrosis in the lower lobe GGO; reticulations in lower lobes (especially if bilateral and symmetrical or associated with signs of fibrosis) were the CT features most frequently associated with SSc-ILD...
July 28, 2021: Rheumatology
#5
Rashmi Roongta, Sumantro Mondal
No abstract text is available yet for this article.
July 28, 2021: Rheumatology
#6
Parikshit Sen, Able Lawrence, Latika Gupta
No abstract text is available yet for this article.
July 28, 2021: Rheumatology
#7
Irina Gessl, Daniel Aletaha, Peter Mandl
No abstract text is available yet for this article.
July 28, 2021: Rheumatology
#8
Kevin Lee, Shokrollah Elahi, Siavash Mashhouri, Carrie Ye
No abstract text is available yet for this article.
July 28, 2021: Rheumatology
#9
Rainjade Chung, Miyad Movassaghi, George Moran, Derek Jones, Kelly Steed, Christopher Anderson
No abstract text is available yet for this article.
July 28, 2021: Rheumatology
#10
Sung Soo Ahn, Jang Woo Ha, Yong-Beom Park, Sang-Won Lee
OBJECTIVE: To investigate the significance of rheumatoid factor (RF) positivity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients. METHODS: AAV patients were divided into groups as follows: RF (+)/ANCA (+) (n = 94), RF (-)/ANCA (+) (n = 80), RF (+)/ANCA (-) (n = 15), and RF (-)/ANCA (-) (n = 25). Their clinical data, organ involvement patterns, laboratory data, and patient outcomes were assessed. Kaplan-Meier analysis and propensity score matching (PSM) were performed to compare outcomes and analyse differences between the groups...
July 28, 2021: Rheumatology
#11
Elena Nikiphorou, Annelies Boonen, Bruno Fautrel, Pascal Richette, Robert Landewé, Désirée van der Heijde, Sofia Ramiro
OBJECTIVES: To investigate the impact of clinical and socioeconomic factors on work disability (WD) in early axial spondyloarthritis (axSpA). METHODS: Patients from the DESIR cohort with a clinical diagnosis of axSpA were studied over 5 years. Time to WD and potential baseline and time-varying predictors were explored, with a focus on socioeconomic (including ethnicity, education, job-type, marital/parental status) and clinical (including disease activity, function, mobility) factors...
July 28, 2021: Rheumatology
#12
Ready Patient One: the role of therapeutic virtual reality in the future management of chronic pain.
Jordan Tsigarides, Nicholas G Shenker, Alexander MacGregor
No abstract text is available yet for this article.
July 28, 2021: Rheumatology
#13
Julia Spierings, Svetlana I Nihtyanova, Emma Derrett-Smith, Kristina E N Clark, Jacob M van Laar, Voon Ong, Christopher P Denton
OBJECTIVES: The aim of this study was to explore outcomes in a cohort of diffuse cutaneous systemic sclerosis (dcSSc) patients fulfilling eligibility criteria for stem cell transplantation (SCT) studies but receiving standard immunosuppression. METHODS: From a large single-centre dcSSc cohort (n = 636), patients were identified using the published SCT trials' inclusion criteria. Patients meeting the trials' exclusion criteria were excluded. RESULTS: Of the 227 eligible patients, 214 met the inclusion criteria for ASTIS, 82 for SCOT and 185 for the UPSIDE trial, and 66 were excluded based on age > 65 years, low DLco, pulmonary hypertension or creatinine clearance <40ml/min...
July 26, 2021: Rheumatology
#14
Amanda D Busby, James Wason, Arthur G Pratt, Adam Young, John D Isaacs, Elena Nikiphorou
OBJECTIVES: Evidence suggests that factors beyond disease activity associate with functional disability in Rheumatoid Arthritis (RA). The primary study objective was to explore associations between comorbidities, sociodemographic factors and functional outcomes at five and 10 years. METHODS: RA patients from two UK prospective cohorts were grouped into low (<1.5) and high (≥1.5) five- and 10-year health assessment questionnaire (HAQ) score. Clinical variables (e...
July 24, 2021: Rheumatology
#15
Sofia Pazmino, Rene Westhovens, Diederik De Cock, Patrick Verschueren
No abstract text is available yet for this article.
July 24, 2021: Rheumatology
#16
Ciro Manzo, Jordi Serra-Mestres, Marco Isetta
No abstract text is available yet for this article.
July 24, 2021: Rheumatology
#17
Alexandre Fagart, Thomas Machet, Guillaume Collet, Thomas Quéméneur, Rim Ben Ticha, Marion Verstraete, Noémie Le Gouellec, Franck Demailly, Clémentine Rousselin
OBJECTIVE: 18F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) is widely used in patients with large-vessel vasculitis. The benefits of FDG-PET/CT in polyarteritis nodosa (PAN) has only ever been assessed in three case reports. Our aim was to describe FDG-PET/CT findings in 10 patients with newly diagnosed PAN. METHODS: This was a retrospective study of patients with PAN who underwent FDG-PET/CT at diagnosis, between 2017 and 2020...
July 24, 2021: Rheumatology
#18
Helena Assunção, Ana R Prata, Jorge Silva, Armando Malcata
No abstract text is available yet for this article.
July 24, 2021: Rheumatology
#19
Masaki Shimizu, Asami Shimbo, Masatoshi Takagi, Katsuhide Eguchi, Masataka Ishimura, Junichi Sugita, Tomohiro Morio, Hirokazu Kanegane
No abstract text is available yet for this article.
July 24, 2021: Rheumatology
#20
Fazira R Kasiem, Marc R Kok, Jolanda J Luime, Ilja Tchetverikov, Kim Wervers, Lindy-Anne Korswagen, Nastasja H A M Denissen, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Faouzia Fodili, Johanna M W Hazes, Marijn Vis
OBJECTIVES: Psoriasis impacts health-related quality of life (HRQoL) in psoriatic arthritis (PsA) patients. However, this is not adequately measured with a general HRQoL questionnaire. The aim of this study was to quantify the degree of psoriasis evolution in PsA patients over the first year of follow up and to evaluate whether the impact of psoriasis on HRQoL can be adequately measured with a dermatology-specific HRQoL questionnaire. METHODS: Data were used from PsA patients in the Dutch south west Early Psoriatic Arthritis cohort...
July 24, 2021: Rheumatology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
